Last reviewed · How we verify
NCT05711225
Transtheoretic Model, Postpartum Smoking Relapse, Smoking Cessation Intervention
NA trial testing smoking cessation intervention given according to the web-based transtheoretic model during pregnancy on postpartum smoking relapse. in Postpartum Smoking Relapse in 70 participants. Completed in 1 December 2022.
1 May 2022
Quick facts
| Lead sponsor | Semra YILMAZ |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | single |
| Primary purpose | health services research |
| Enrollment | 70 |
| Start date | 24 March 2021 |
| Primary completion | 1 May 2022 |
| Estimated completion | 1 December 2022 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- smoking cessation intervention given according to the web-based transtheoretic model during pregnancy on postpartum smoking relapse.
Conditions studied
- Postpartum Smoking Relapse — all drugs for Postpartum Smoking Relapse →
Sponsor
Semra YILMAZ
Who can join
Eligibility, female only, with Postpartum Smoking Relapse. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The postpartum period is an important opportunity to improve maternal and fetal health by preventing smoking relapse in women. To achieve this goal, digital platforms, which are the latest technological developments are used. However, studies using digital platforms on smoking cessation and postpartum smoking relapse in pregnant women are limited in this area. The research was carried out to determine the effect of smoking cessation intervention prepared in line with the transtheoretic model on the digital platform, on preventing smoking relapse in the postpartum period. As a result of the research, it is thought that nurses will guide their professional practices with an evidence-based up-to-date approach.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05711225
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Postpartum Smoking Relapse
Currently open trials in the same condition.
- NCT04098874 — Bupropion for the Prevention of Postpartum Smoking Relapse · Phase 4 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05711225 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Semra YILMAZ
- Last refreshed: 2 February 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05711225.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing